Intralesional administration of meglumine antimoniate (MA) as an alternative treatment for cutaneous leishmaniasis: a case report

dc.creatorSouza, Marcos Vilela de
dc.creatorCherem, José
dc.creatorSantos Júnior, Gilson Argolo dos
dc.creatorCésar, Antônia Amanda da Silva
dc.creatorNarciso, Thiago Pasqua
dc.creatorAlvarenga, Ingrid Marciano
dc.creatorBarçante, Thales Augusto
dc.creatorBarçante, Joziana Muniz de Paiva
dc.date.accessioned2023-06-15T13:24:42Z
dc.date.available2023-06-15T13:24:42Z
dc.date.issued2023
dc.description.abstractCutaneous leishmaniasis (CL) is not a life-threatening condition, the treatment of which can cause serious adverse effects and sometimes lead to death. In this study, we report a case of success in the treatment of LC of a 2.5 cm lesion located in the neck region of a 22-year-old man treated with intralesional meglumine antiomoniate (IL-MA) without adverse effects and without recurrence or complications after 18 months of follow-up. The results suggest that the treatment of CL lesions with IL-MA is simple, efficient and safe.pt_BR
dc.identifier.citationSOUZA, M. V. de et al. Intralesional administration of meglumine antimoniate (MA) as an alternative treatment for cutaneous leishmaniasis: a case report. Brazilian Journal of Health Review, Curitiba, v. 6, n.1, p. 3323-3328, Jan./Feb. 2023.pt_BR
dc.identifier.urihttps://repositorio.ufla.br//handle/1/56987
dc.identifier.urihttps://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/57214pt_BR
dc.languageen_USpt_BR
dc.rightsopenAccesspt_BR
dc.sourceBrazilian Journal of Health Reviewpt_BR
dc.subjectLeishmaniapt_BR
dc.subjectGlucantimept_BR
dc.subjectNeglected diseasept_BR
dc.subjectDoenças negligenciadaspt_BR
dc.titleIntralesional administration of meglumine antimoniate (MA) as an alternative treatment for cutaneous leishmaniasis: a case reportpt_BR
dc.typeArtigopt_BR

Arquivos

Licença do pacote

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
956 B
Formato:
Item-specific license agreed upon to submission
Descrição: